Compositions and methods for cancer therapy
US11986512B2 · kind B2 · utility
0Cited by
0References
44Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 26, 2022 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Oct 26, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising resolvins and their use in methods of treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.